npr.org
Advisers to the Food and Drug Administration voted 20-0 to recommend that the
agency authorize Moderna’s vaccine for emergency use during the pandemic. There
was a single abstention.
over 3 years ago
npr.org
This is the first new drug approved for Alzheimer’s disease since 2003. It’s the
first to show significant progress against the sticky brain plaques that are the
hallmark of Alzheimer’s disease.
almost 3 years ago
npr.org
The approval replaces the emergency use authorizations granted last December and
could make it easier for employers, the military and universities to mandate
vaccination.
over 2 years ago
npr.org
Pfizer says data support its request for Food and Drug Administration approval
of a third dose of COVID vaccine about six months after the second dose in
people 16 years and older.
over 2 years ago
npr.org
Johnson & Johnson has asked the Food and Drug Administration to authorize a
booster for people 18 and older six months after initial immunization, with an
option to vaccinate after two months.
over 2 years ago
npr.org
A panel of experts voted to recommend that the Food and Drug Administration
authorize a booster dose of the Johnson & Johnson COVID vaccine at least two
months after the first shot.
over 2 years ago
npr.org
The Food and Drug Administration also gave an OK to boosters that differ from
the vaccine originally used to immunize people against COVID-19. A mix-and-match
approach could ease the booster rollout.
over 2 years ago
Search by beat, location, outlet & position to find the right journalists for your story.
Sign up for freenpr.org
Moderna says a study in kids 6 to 11 found two doses of the company’s COVID-19 vaccine given 28 days apart produced a strong antibody response.
over 2 years ago
npr.org
CDC director Rochelle Walensky gave the green light to boosters just hours after
a panel of vaccine advisors voted unanimously to recommend boosters for anyone
18 and older.
over 2 years ago
npr.org
If the Food and Drug Administration authorizes use of the drug, called
molnupiravir, it would be the first oral COVID-19 treatment that could be taken
at home.
over 2 years ago
npr.org
The research finds that the medicine, called Paxlovid, was effective in
preventing hospitalization and death when taken by people with mild to moderate
illness within a few days of symptoms.
over 2 years ago
npr.org
In a highly anticipated decision, the Food and Drug Administration authorized
Pfizer’s Paxlovid as the first antiviral pill to treat COVID-19 at home.
over 2 years ago
npr.org
The medicine, called molnupiravir, is taken twice a day for five days and works
by preventing the virus from replicating. Merck says it will have 10 million
packs available by the end of the month.
over 2 years ago
npr.org
The authorization comes in the midst of an explosion of COVID-19 cases
nationwide driven by the omicron variant — a surge that has brought a spike in
pediatric hospitalizations.
about 2 years ago
npr.org
Pfizer and BioNTech are planning to ask the Food and Drug Administration to
authorize a second COVID-19 booster shot for people age 65 and older.
about 2 years ago
npr.org
The vaccines now in use are based on the form of the virus that circulated at
the beginning of the pandemic and are less effective against the omicron
variant. New options are in the works.
almost 2 years ago
npr.org
Advisers to the Food and Drug Administration overwhelmingly voted to recommend
that it authorize Novavax’s two-dose vaccine against COVID-19.
almost 2 years ago
npr.org
The new shots from Moderna and Pfizer-BioNTech target both the original strain
of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are
catching now.
over 1 year ago
npr.org
Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation’s approach to vaccinating people against COVID-19.
about 1 year ago
npr.org
A panel of doctors and scientists advising the Centers for Disease Control and Prevention voted to recommend that people 6 months of age and older get new COVID boosters this fall.
7 months ago
npr.org
Hungarian-born biochemist Katalin Karikó and American immunologist Drew Weissman found that a chemical change to genetic code called mRNA eliminated a problematic side effect when used in vaccines.
6 months ago